122 related articles for article (PubMed ID: 26868304)
1. Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.
Perumal V; Pohl S; Keane KN; Arfuso F; Newsholme P; Fox S; Dharmarajan A
Exp Cell Res; 2016 Feb; 341(2):218-24. PubMed ID: 26868304
[TBL] [Abstract][Full Text] [Related]
2. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
Perumal V; Dharmarajan AM; Fox SA
Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
[TBL] [Abstract][Full Text] [Related]
3. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
[TBL] [Abstract][Full Text] [Related]
4. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
5. Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells.
Fox SA; Richards AK; Kusumah I; Perumal V; Bolitho EM; Mutsaers SE; Dharmarajan AM
Biochem Biophys Res Commun; 2013 Oct; 440(1):82-7. PubMed ID: 24041698
[TBL] [Abstract][Full Text] [Related]
6. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
7. Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.
Perumal V; Arfuso F; Chen Y; Fox S; Dharmarajan AM
Mol Cell Biochem; 2018 Jun; 443(1-2):205-213. PubMed ID: 29185158
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells.
Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A
Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562
[TBL] [Abstract][Full Text] [Related]
9. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells.
Valenti D; de Bari L; Manente GA; Rossi L; Mutti L; Moro L; Vacca RA
Biochim Biophys Acta; 2013 Dec; 1832(12):2085-96. PubMed ID: 23911347
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
[TBL] [Abstract][Full Text] [Related]
11. Secreted frizzled-related protein 4 regulates two Wnt7a signaling pathways and inhibits proliferation in endometrial cancer cells.
Carmon KS; Loose DS
Mol Cancer Res; 2008 Jun; 6(6):1017-28. PubMed ID: 18567805
[TBL] [Abstract][Full Text] [Related]
12. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
15. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
[TBL] [Abstract][Full Text] [Related]
16. Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.
Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry JP; Guertler R; Hornung D; Mueller R; Fink DA; Hacker NF; Heinzelmann-Schwarz VA
PLoS One; 2012; 7(2):e31885. PubMed ID: 22363760
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
18. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
20. Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction.
Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
Int J Oncol; 2014 Oct; 45(4):1769-77. PubMed ID: 25096993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]